Navigation Links
Plan to Adopt Vaccine Purchase Plan for Diseases

The Group of Seven industrialized nations on Friday plans to sign an agreement to provide $1.5 billion to develop vaccines for //diseases - including HIV/AIDS, TB //and malaria - that largely affect developing countries, the government of Italy announced on Tuesday.

Under the program, donor countries will pledge to buy vaccines that are being developed at a preferential price when they are available. This would create a financial incentive for drug companies to develop vaccines for diseases that largely affect developing countries.

Canada, Italy, Norway and the United Kingdom plan to make funding pledges on Friday. According to Italian government sources, Italy plans to pledge $500 million; the United Kingdom is expected to pledge $400 million; and Canada and Norway are expected to pledge $200 million each. Officials from the G7 countries plan to explain the program to Pope Benedict XVI on Friday ahead of the G7 meeting in Essen, Germany, according to the Italian economy ministry.

Leaders of the Group of Eight industrialized nations at their summit in July 2006 did not act on an opportunity to adopt a similar advance market commitment plan aimed at funding the development of vaccines for diseases such as HIV/AIDS, TB and malaria. Under the plan, G8 nations would provide between $800 million and $6 billion to subsidize the purchase of new vaccines.

Wealthy nations also would provide funding to pharmaceutical companies when they produce safe and effective vaccines, and drug makers would sell the vaccines at reduced prices in developing countries when G8 nations have provided the promised amount. The total amount of the G8 pledge and the price per dose of each vaccine would be negotiated ahead of time.

Source-Kaiser Family Foundation
SRI
'"/>




Page: 1

Related medicine news :

1. Adopting Easier Methods To Screen Insulin Resistance
2. Diabetics Should Adopt Better Preventive Measures
3. Poultry Workers To Adopt Anti-Flu Guidelines
4. Exiled Tibetans In India To Adopt Organic Farming
5. Ker Govt To Adopt Orphaned Kids Of HIV Infected Parents
6. Kerala Govt To Adopt Orphaned Kids Of HIV Infected Parents
7. Sex Workers Adopt IT Solutions to Fight AIDS
8. Gates Foundation Adopts Fight against Encephalitis
9. Vice President Urges Dental Institutes to Adopt Some Villages
10. Haryana Adopts New Rules for Private Schools
11. China Bars Obese from Adopting Children
Post Your Comments:
(Date:12/2/2008)...rgoed for Tuesday, December 2, 2008 at 3 pm CST)--...Medical University of South Carolina in Charleston... of cancer from exposure to radiation during compu... overstated and that new estimates are several tim...he MUSC researchers presented their findings at th...
(Date:12/2/2008)...ec. 2 United American He...s and provides comprehensive healthcare,managemen...ssee, today,announced that its Board of Directors...zing the Company to repurchase up to $1.0 million ...gram allows for the Company,s common shares to be ...
(Date:12/2/2008)...ec. 2 Today a group of...ns, elected officials and other community leaders ... in Detroit/Wayne County to solidify participants,...e and economic successes and challenges play a rol...of the opening session of a three-day discussion t...
(Date:12/2/2008)... The Health Story Project was annou...ormerly known as “Clinical Document Architec...DA4CDT will continue as the label for the technica... to Health Level Seven (HL7) for ballot. The new n...ire EON) December 2, 2008 -- "Our group has ...
Breaking Medicine News(10 mins):Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5
...sleep deprived people should never get behind the ...can hamper the coordination of horizontal eye mov...he study was conducted on a group of 6 participant...Metropolitan University, who asked the volunteers ...
...a could be releasing dangerous levels of radioacti...'s standard for allowable levels of tritium are 10... higher than Europe. As a precautionary measure t...en under the age of 4 and pregnant women shouldn't...
...rs over the slight incisions on his patient's back...g vacuum , the thick dark blood slowly oozed out o...syrians, the Chinese and the ancient Egyptians all...t the corrupt blood," said Hajam as he deftly drai...
...a computerized garment that they say can help doct...on and schizophrenia . The high-tech garment is pa...g rate, blood pressure, skin temperature, body mov...orted online edition of the Daily Mail. It was i...
Other Medicine News:Health News:Tritium Risks at New Heights 2Health News:Ancient Healing Technique Gains New Popularity in Iraq 2Health News:Researchers Have Developed Computerized Garment to Diagnose Mental Illness 2
(Date:12/1/2008).../ -- Vical Incorporated (Nasdaq: VICL ) announce...yment from Merck & Co., Inc. based on Merck,s ...an investigational plasmid DNA (pDNA) cancer vacci...gene delivery technology and encodes human telomer...bject of separate license agreement. , , "T...
(Date:11/27/2008)...ymphoblastic leukemia relapse cases arise from a c... , MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNewswi...Hospital have identified distinctive genetic chang...hoblastic leukemia (ALL) that cause relapse. The f...r ALL relapse in children and, ultimately, in adul...
(Date:11/25/2008)...Newswire/ -- Kleinert Kutz and University of Loui...d transplant on Messina, New York resident, Jan "E...d Care Center on Monday, November 24. The innovat...shortly after 9 p.m. in a record nine hours. , ...h/20081125/DC48555-a ) , (Photo: http://www.n...
(Date:11/25/2008)... to Assess Survival of Patients Receiving Litx ver...patocellular Carcinoma , , BELLEVUE, Wash.,...Inc. (LSO) today announced the completion of enrol...Infusion Therapy(TM) (Litx(TM)) as a treatment for... known as hepatoma or primary liver cancer. , ...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 1Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 4Clot Busting Treatment Improves Bleeding Stroke Outcomes 19289 1Clot Busting Treatment Improves Bleeding Stroke Outcomes 19289 2Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 1Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 2Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 3Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 4Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 5FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 1FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 2FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 3FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 4FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 5FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 6FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 7FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 8FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 9
...N, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarmi...of CANCER (a peer-reviewed,journal of the American...taking the standard five-year regimen of the hormo...continue therapy early.(1), According to the autho...or issue that may negatively affect treatment effi...
...LPHIA, March 15, 2007-- The cause of one notorious...reat the ongoing,threat of another childhood disea... Research, researchers from Stony Brook University...orm of poliovirus,is effective in obliterating neu...been previously vaccinated against the virus. , By...
Other Medicine Technology:One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 2Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 4
...t is a clinical chemistry assay that detects Ische...obalt binding capacity of albumin in a patient ser...A is produced when circulating albumin comes in co...chemia, the N-terminus of albumin is altered throu...
...t is a clinical chemistry assay that detects Ische...obalt binding capacity of albumin in a patient ser...A is produced when circulating albumin comes in co...chemia, the N-terminus of albumin is altered throu...
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl
...t is a clinical chemistry assay that detects Ische...obalt binding capacity of albumin in a patient ser...A is produced when circulating albumin comes in co...chemia, the N-terminus of albumin is altered throu...
Medicine Products: